Safety and efficacy of laquinimod for Huntington's disease (LEGATO-HD): a multicentre, randomised, double-blind, placebo-controlled, phase 2 study

  1. Reilmann, R.
  2. Anderson, K.E.
  3. Feigin, A.
  4. Tabrizi, S.J.
  5. Leavitt, B.R.
  6. Stout, J.C.
  7. Piccini, P.
  8. Schubert, R.
  9. Loupe, P.
  10. Wickenberg, A.
  11. Borowsky, B.
  12. Rynkowski, G.
  13. Volkinshtein, R.
  14. Li, T.
  15. Savola, J.-M.
  16. Hayden, M.
  17. Gordon, M.F.
  18. Guttman, M.
  19. Raymond, L.
  20. Mendis, T.
  21. Suchowersky, O.
  22. Corey-Bloom, J.
  23. Geschwind, M.D.
  24. Marshall, F.J.
  25. Marder, K.S.
  26. Nance, M.
  27. Racette, B.
  28. Bang, J.
  29. Segro, V.
  30. McDonell, K.
  31. Kamholz, J.
  32. LeDoux, M.S.
  33. Sanchez-Ramos, J.
  34. DeMichele, G.
  35. Mariotti, C.
  36. Squitieri, F.
  37. Soliveri, P.
  38. Cortelli, P.
  39. Muñoz García, J.E.
  40. Kulisevsky Bojarski, J.
  41. López-Sendón Moreno, J.L.
  42. Berganzo Corrales, K.
  43. Cubo, E.
  44. García Moreno, J.M.
  45. Orth, M.
  46. Priller, J.
  47. Saft, C.
  48. Weindl, A.
  49. Winkler, J.
  50. Craufurd, D.
  51. Miedzybrodzka, Z.
  52. Rickards, H.
  53. Davies, R.R.
  54. Lahiri, N.
  55. Ruddy, D.
  56. Komati, S.K.
  57. Quarrell, O.W.J.
  58. Correira Guedes, L.
  59. Roos, R.A.C.
  60. Zalyalova, Z.
  61. Illarioshkin, S.
  62. Gustov, A.
  63. Klempir, J.
  64. Show all authors +
Journal:
The Lancet Neurology

ISSN: 1474-4465 1474-4422

Year of publication: 2024

Volume: 23

Issue: 3

Pages: 243-255

Type: Article

DOI: 10.1016/S1474-4422(23)00454-4 GOOGLE SCHOLAR

Sustainable development goals